BCI Pharma

Innovate is key for us and this lead to the discovery of an FLT3 kinase inhibitor very selective and potent compare to benchmarker in clinical stage.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Montpellier, France
  • Currency EUR
  • Founded 2013
  • Employees 4
  • Website bci-pharma.com

Company Summary

BCI Pharma validates and develops platforms/technologies which served internal (research project) and external clients (collaboration/partnership).

The first one is a really innovative kinase inhibitor Platform which generated very potent and selective drugs.
Our most advanced project is the developpment of a compound able to cure accute myeloid leukemia (AML) through inhibition of the FLT3 kinase.
The same series of FLT3 inhibitors will be explore in neuropathic pain model.
We initiate others research project based on our technology.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free